Alternatives to Schrödinger

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

AI-powered molecular simulation for accelerating drug discovery and materials science.

Bsport - Nhà cái cá độ thể thao, cá cược bóng đá uy tín 2026. Sảnh B-Sport, K-Sports, S-Sport độc quyền. Sân chơi cá cược số 1 thị trường VN được bình chọn.

AI-powered website builder that creates professional websites in minutes from a simple description.

Platform to accelerate scientific discovery using AI.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Kimerachems is a startup focused on developing advanced chemical synthesis solutions.

Life science company pioneering drug discovery with AI and advanced technologies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing advanced quantum computing algorithms and software for complex problem-solving.

A global contract research organization specializing in preclinical and translational oncology research.

AI platform for computational biologists to accelerate drug discovery and therapeutic development.

Develops a computational model of the human body for drug discovery and development.

A global oncology company developing and commercializing innovative cancer treatments.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-powered research assistant for scientific literature review and data extraction.

Pasqal develops quantum computing solutions for complex scientific and industrial problems.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Quantum computing application and algorithm development

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

International specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

Building the world's first scientific superintelligence platform and autonomous labs.

AI-powered materials science and discovery platform to accelerate scientific breakthroughs.

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

Astradyne is a startup focused on developing advanced AI for scientific discovery and research.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Finnish quantum computer manufacturer building fault-tolerant quantum computers for various industries.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing oral small molecule medicines for immunological and chronic diseases.

AI-native science startup building novel inventions and innovations through advanced AI systems.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing highly targeted, small molecule medicines.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).